You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Safety of disease-modifying treatments in SARS-CoV-2 antibody-positive multiple sclerosis patients
|
|---|---|
| Published in |
Multiple Sclerosis and Related Disorders, January 2021
|
| DOI | 10.1016/j.msard.2021.102754 |
| Pubmed ID | |
| Authors |
Giulia Mallucci, Antonio Zito, Fausto Baldanti, Matteo Gastaldi, Beatrice Dal Fabbro, Diego Franciotta, Roberto Bergamaschi |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 84 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 84 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 10 | 12% |
| Student > Master | 8 | 10% |
| Student > Ph. D. Student | 7 | 8% |
| Student > Doctoral Student | 6 | 7% |
| Researcher | 5 | 6% |
| Other | 11 | 13% |
| Unknown | 37 | 44% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 21 | 25% |
| Neuroscience | 6 | 7% |
| Nursing and Health Professions | 4 | 5% |
| Economics, Econometrics and Finance | 3 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 4% |
| Other | 8 | 10% |
| Unknown | 39 | 46% |
Attention Score in Context
This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 March 2021.
All research outputs
#4,182,819
of 25,387,668 outputs
Outputs from Multiple Sclerosis and Related Disorders
#748
of 3,095 outputs
Outputs of similar age
#107,118
of 523,010 outputs
Outputs of similar age from Multiple Sclerosis and Related Disorders
#40
of 158 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,095 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 523,010 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 158 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.